We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
10 Year Est. Return
AUM
$246M
AUM Growth
+$3.68M
Cap. Flow
-$4.96M
Cap. Flow %
-2.02%
Top 10 Hldgs %
57.95%
Holding
52
New
1
Increased
15
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$227K
2
HXL icon
Hexcel
HXL
+$49.1K
3
ABT icon
Abbott
ABT
+$35K
4
CRM icon
Salesforce
CRM
+$34.6K
5
AAPL icon
Apple
AAPL
+$31.1K

Top Sells

Rank Stock Value
1
COKE icon
Coca-Cola Consolidated
COKE
+$1.04M
2
XOM icon
ExxonMobil
XOM
+$462K
3
DE icon
Deere & Co
DE
+$428K
4
CPRT icon
Copart
CPRT
+$417K
5
ARCC icon
Ares Capital
ARCC
+$365K

Sector Composition

Rank Sector Weight
1 Industrials 34.85%
2 Technology 16.94%
3 Financials 14.33%
4 Consumer Discretionary 10.43%
5 Healthcare 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.66T
$549K 0.22%
2,025
ACN icon
27
Accenture
ACN
$101B
$531K 0.22%
1,800
+100
+6% +$28.6K
UPS icon
28
United Parcel Service
UPS
$90.8B
$520K 0.21%
2,500
+100
+4% +$20K
RTX icon
29
RTX Corp
RTX
$294B
$455K 0.18%
5,329
V icon
30
Visa
V
$683B
$408K 0.17%
1,743
CRM icon
31
Salesforce
CRM
$156B
$397K 0.16%
1,625
+150
+10% +$34.6K
MCD icon
32
McDonald's
MCD
$191B
$395K 0.16%
1,711
-265
-13% -$61.7K
ABT icon
33
Abbott
ABT
$182B
$388K 0.16%
3,350
+300
+10% +$35K
AMGN icon
34
Amgen
AMGN
$210B
$378K 0.15%
1,550
-25
-2% -$6.15K
ITW icon
35
Illinois Tool Works
ITW
$83B
$374K 0.15%
1,675
ABBV icon
36
AbbVie
ABBV
$433B
$372K 0.15%
3,300
+200
+6% +$22.5K
CTVA icon
37
Corteva
CTVA
$50.7B
$367K 0.15%
8,284
+600
+8% +$27.7K
PFE icon
38
Pfizer
PFE
$145B
$360K 0.15%
9,197
CAT icon
39
Caterpillar
CAT
$404B
$348K 0.14%
1,600
-30
-2% -$6.93K
STZ icon
40
Constellation Brands
STZ
$22.4B
$345K 0.14%
1,475
+125
+9% +$29.3K
AXP icon
41
American Express
AXP
$233B
$322K 0.13%
1,950
+150
+8% +$23.5K
MMM icon
42
3M
MMM
$91.4B
$278K 0.11%
1,672
+57
+4% +$9.51K
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.59T
$256K 0.1%
2,100
JPM icon
44
JPMorgan Chase
JPM
$950B
$233K 0.09%
1,500
+150
+11% +$23.6K
CSCO icon
45
Cisco
CSCO
$480B
$228K 0.09%
4,300
-3,500
-45% -$184K
MAR icon
46
Marriott International
MAR
$90.4B
$215K 0.09%
+1,575
New +$227K
COKE icon
47
Coca-Cola Consolidated
COKE
$12B
$208K 0.08%
38,470
-29,500
-43% -$1.04M
SO icon
48
Southern Company
SO
$107B
$200K 0.08%
3,300
ARCC icon
49
Ares Capital
ARCC
$13.8B
-19,491
Closed -$365K
XOM icon
50
ExxonMobil
XOM
$638B
-8,272
Closed -$462K

Similar funds

Weybosset Research & Management's Q2 2021 Portfolio in Review

As of Q2 2021, Weybosset Research & Management held 52 positions worth $246M, up 1.5% from $242M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Weybosset Research & Management's Q2 2021 filing shows 1 new, 15 increased, 26 reduced and 2 closed positions. Its largest new stake was Marriott International: 1,575 shares worth $215K. The largest sale was Coca-Cola Consolidated, an estimated $1.04M.

By sector, the portfolio is most concentrated in Industrials at 35% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

  • Weybosset Research & Management's largest Q2 2021 buy was Marriott International: 1,575 shares worth $215K.
  • Weybosset Research & Management added most to Hexcel in Q2 2021, an estimated $49.1K increase.
  • Weybosset Research & Management's biggest Q2 2021 reduction was Coca-Cola Consolidated, cutting an estimated $1.04M.
  • Weybosset Research & Management fully exited ExxonMobil in Q2 2021, selling an estimated $462K.
  • Weybosset Research & Management's ten largest holdings make up 58% of its $246M portfolio in Q2 2021.
  • Weybosset Research & Management opened 1 new position and closed 2 in Q2 2021.
  • Weybosset Research & Management's portfolio value rose 1.5% quarter-over-quarter to $246M.

Based on Weybosset Research & Management's 13F filing for Q2 2021, filed 26 Jul 2021.